Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25437
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSpanos, Cassandra-
dc.contributor.authorGrace, Julian A-
dc.contributor.authorLeemaqz, Shalem Y-
dc.contributor.authorBrownhill, Adam-
dc.contributor.authorCundill, Pauline-
dc.contributor.authorLocke, Peter-
dc.contributor.authorWong, Peggy-
dc.contributor.authorZajac, Jeffrey D-
dc.contributor.authorCheung, Ada S-
dc.date2020-11-25-
dc.date.accessioned2020-12-06T21:53:56Z-
dc.date.available2020-12-06T21:53:56Z-
dc.date.issued2021-01-
dc.identifier.citationThe Journal of Sexual Medicine 2021; 18(1): 201-208en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25437-
dc.description.abstractThere are 2 common approaches to assess an individual before commencing of gender-affirming hormone therapy (GAHT); a mental health practitioner assessment and approval or an informed consent model undertaken with a primary care general practitioner (GP). In a primary care clinic practising an Informed Consent Model of care to initiate GAHT, we aimed to firstly describe the proportion and characteristics of patients referred for secondary consultation to a mental health practitioner (MH referred) and secondly, we aimed to measure patient satisfaction. A retrospective audit of all new patients with a transgender or gender diverse identity presenting to a primary care clinic in Melbourne, Australia was performed between March 2017 and March 2019. In those newly seeking GAHT, de-identified data were obtained including presence of secondary mental health practitioner referral, time to GAHT commencement and co-occurring mental health conditions. A separate survey assessed patient satisfaction. Mental health conditions and overall patient satisfaction in those referred for secondary mental health consultation (MH referred) were compared with those who were not (GP assessed). Of 590 new consultations, 309 were newly seeking GAHT. Referrals for secondary mental health assessment before GAHT occurred in 8%. The GP-assessed group commenced GAHT at median 0.9 months (0.5-1.8) after initial consultation compared with 3.1 months (1.3-4.0), P < .001 in the MH-referred group. The MH-referred group was more likely to have post-traumatic stress disorder (adjusted P = .036) and schizophrenia (adjusted P = .011). Of 43 respondents to the survey, a higher proportion in the GP-assessed group was extremely satisfied with their overall care compared with the MH-referred group (P < .01). Notably, 80% in the GP-assessed group chose to seek mental health professional support. Initiation of GAHT can be performed in primary care by GPs using an informed consent model and is associated with high patient satisfaction. Mental health professionals remain a key source of support. This retrospective audit did not randomize patients to pathways to initiate GAHT. Follow-up duration was short. Responder bias to survey with low response rates may overestimate patient satisfaction. This is one of the first studies to evaluate an informed consent model of care. More widespread uptake of an informed consent model of care to initiate GAHT by primary care physicians has the potential for high patient satisfaction and may be a practical solution to reduce waiting lists in gender clinics. Spanos C, Grace JA, Leemaqz SY, et al. The Informed Consent Model of Care for Accessing Gender-Affirming Hormone Therapy Is Associated With High Patient Satisfaction. J Sex Med 2020;XX:XXX-XXX.en_US
dc.language.isoeng-
dc.subjectGender-Affirming Hormone Therapyen_US
dc.subjectInformed Consent Modelen_US
dc.subjectMental Healthen_US
dc.subjectTransgenderen_US
dc.titleThe Informed Consent Model of Care for Accessing Gender-Affirming Hormone Therapy Is Associated With High Patient Satisfaction.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThe jJournal of Sexual Medicineen_US
dc.identifier.affiliationCollege of Medicine and Public Health, Flinders University, South Australia, Australiaen_US
dc.identifier.affiliationPandanus Medical NT, Millner, Northern Territory, Australiaen_US
dc.identifier.affiliationEquinox Gender Diverse Health Centre, Thorne Harbour Health, Fitzroy, Victoria, Australiaen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.doi10.1016/j.jsxm.2020.10.020en_US
dc.type.contentTexten_US
dc.identifier.pubmedid33249011-
local.name.researcherCheung, Ada S
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Nov 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.